RxDoctor Payments Data

John Horneff, MD

Orthopaedic Surgery · Philadelphia, PANPI 1053639302

Payments from drug & device makers

$32,550in general payments, 2019–2025

Across 100 payments — averaging $325.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$17K
  • Tigon Medical LLC$6K
  • Liberty Surgical Inc.$4K
  • Catalyst Orthoscience$2K
  • Biedermann Motech, Inc.$1K
  • Zimmer Biomet$933
  • plus $1K from 9 others

What the payments were for

  • Royalty or licence$3,09410%
  • Consulting fees$17,00952%
  • Speaking & faculty fees$5002%
  • Travel & lodging$4,01212%
  • Food & beverage$4,34313%
  • Education$3,59211%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker43$16,882
Tigon Medical LLC12$6,101
Liberty Surgical Inc.6$3,864
Catalyst Orthoscience3$1,948
Biedermann Motech, Inc.5$1,472
Zimmer Biomet11$933
Arthrex4$563
Exactech, Inc.4$387
Smith+Nephew3$154
Encore Medical, LP2$72
Paladin Technology Solutions2$67
Heraeus Medical, LLC.2$42
Integra Lifesciences Corporation1$28
Ossur Americas, Inc.1$18
FX Shoulder Solutions, Inc1$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$32,550 in reported general payments places this provider in the 80th percentile of 1,048 orthopaedic surgery providers in Pennsylvania.

See all orthopaedic surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$218,609
Medicare patients
406
Services billed
1,274

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam81$296
Methylprednisolone32$216

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →